Overview of case definitions and contact tracing indications in the 2022 monkeypox outbreak.
Mpox outbreak
epidemiological and virological surveillance
monkeypox
public health authorities
Journal
Le infezioni in medicina
ISSN: 2532-8689
Titre abrégé: Infez Med
Pays: Italy
ID NLM: 9613961
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
11
2022
accepted:
28
01
2023
entrez:
13
3
2023
pubmed:
14
3
2023
medline:
14
3
2023
Statut:
epublish
Résumé
In 2022, a new outbreak of the Mpox virus occurred outside of Africa, its usual endemic area. The virus was detected in European, American, Asian, and Oceanian countries where Mpox is uncommon or had not been reported previously and where the spread was rapid. The study aims to compare the case definition and the indications for contact tracing in case of Mpox infection among the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and four European Countries. From August 2022 to November 2022, we conducted research, first on the WHO and ECDC official websites and then on the official websites of the Ministry of Health or National Health Agencies of four European Countries (Italy, France, Spain, and Portugal). All reports found were compared to enlighten the differences in the definition of the case and indications for contact tracing. The WHO divides the case definition into four categories: suspected, probable, confirmed, and discarded, while the ECDC divides cases into confirmed and probable. The ECDC defines contact as close and others, while the WHO divides it into high, medium, and minimal risk. The four countries analyzed show heterogeneity in both the case definitions and the indications for contact tracing. Our analysis revealed heterogeneity in the case definition between the WHO and ECDC. Different countries followed different indications or have given their indications for both the case definition and contact tracing indications. Harmonization strengthens public health preparedness and response and creates unified communication.
Sections du résumé
Background
UNASSIGNED
In 2022, a new outbreak of the Mpox virus occurred outside of Africa, its usual endemic area. The virus was detected in European, American, Asian, and Oceanian countries where Mpox is uncommon or had not been reported previously and where the spread was rapid. The study aims to compare the case definition and the indications for contact tracing in case of Mpox infection among the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and four European Countries.
Methods
UNASSIGNED
From August 2022 to November 2022, we conducted research, first on the WHO and ECDC official websites and then on the official websites of the Ministry of Health or National Health Agencies of four European Countries (Italy, France, Spain, and Portugal). All reports found were compared to enlighten the differences in the definition of the case and indications for contact tracing.
Results
UNASSIGNED
The WHO divides the case definition into four categories: suspected, probable, confirmed, and discarded, while the ECDC divides cases into confirmed and probable. The ECDC defines contact as close and others, while the WHO divides it into high, medium, and minimal risk. The four countries analyzed show heterogeneity in both the case definitions and the indications for contact tracing.
Conclusions
UNASSIGNED
Our analysis revealed heterogeneity in the case definition between the WHO and ECDC. Different countries followed different indications or have given their indications for both the case definition and contact tracing indications. Harmonization strengthens public health preparedness and response and creates unified communication.
Identifiants
pubmed: 36908385
doi: 10.53854/liim-3101-3
pii: 1124-9390_31_1_2023_013-019
pmc: PMC9994831
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
13-19Déclaration de conflit d'intérêts
Conflict of interest The authors declare no conflict of interest.
Références
Infect Dis Poverty. 2022 Jul 7;11(1):80
pubmed: 35794644
Zool Res. 2022 Jul 18;43(4):612-614
pubmed: 35758536
Viruses. 2022 Jun 14;14(6):
pubmed: 35746765
Drugs. 2022 Jun;82(9):957-963
pubmed: 35763248
J Prev Med Hyg. 2021 Jul 30;62(2):E382-E385
pubmed: 34604577
Lancet Infect Dis. 2022 Jul;22(7):929-931
pubmed: 35636447
Infez Med. 2022 Sep 1;30(3):372-391
pubmed: 36148174
J Prev Med Hyg. 2021 Sep 15;62(3):E782-E788
pubmed: 34909509
Clin Infect Dis. 2021 Jul 15;73(2):e434-e436
pubmed: 32770226
Vaccines (Basel). 2022 Dec 07;10(12):
pubmed: 36560502
BMJ. 2022 Nov 2;379:e073153
pubmed: 36323407
Lancet. 2022 Jul 30;400(10349):337
pubmed: 35908560
Parasitol Res. 2022 Mar;121(3):781-803
pubmed: 35122516
Mil Med Res. 2022 Jun 13;9(1):29
pubmed: 35698241
Lancet. 2022 Jun 25;399(10344):2345-2346
pubmed: 35716671
Lancet Infect Dis. 2022 Jul;22(7):950
pubmed: 35752185
PLoS Negl Trop Dis. 2022 Feb 11;16(2):e0010141
pubmed: 35148313
J Med Microbiol. 2019 Nov;68(11):1596-1603
pubmed: 31526454
Ann Clin Microbiol Antimicrob. 2022 Jun 15;21(1):26
pubmed: 35706004
Herz. 2020 Jun;45(4):313-315
pubmed: 32333025
Lancet. 2022 Jun 18;399(10343):2254-2255
pubmed: 35717977
MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1018-1022
pubmed: 35951487
J Med Virol. 2022 Sep;94(9):4034-4036
pubmed: 35614026
Infez Med. 2022 Sep 1;30(3):323-327
pubmed: 36148175
Infez Med. 2022 Dec 1;30(4):610-618
pubmed: 36482948
Lancet Infect Dis. 2022 Aug;22(8):1153-1162
pubmed: 35623380
N Engl J Med. 2004 Jan 22;350(4):342-50
pubmed: 14736926
PLoS One. 2013;8(2):e55488
pubmed: 23408990
Model Earth Syst Environ. 2022;8(3):3423-3434
pubmed: 34667829